Depressive disorders are the most frequent psychiatric comorbidity in epilepsy. Depressive mood affects negatively quality of life (QOL) ratings, sometimes having greater impact than seizure-related variables. Women with epilepsy are a specifi c subgroup at risk of comorbid depression in consequence of certain biopsychosocial demands. The AIM of this study was to assess the relative contribution of mood, seizure-related and demographic variables on QOL scores in women with epilepsy of childbearing age. SUBJECTS AND METHODS: A psychiatric assessment was carried out of 65 women with epilepsy (aged 18-55, mean 37.23 ± 11.83 yrs). Comorbid depressive disorder was diagnosed according to ICD-10 criteria. Its severity was evaluated on the Hamilton Depression Rating Scale (HAMD-17). A questionnaire for demographic and seizure-related variables was completed. Two self-assessment questionnaires were administered: the Seizure Severity Questionnaire (SSQ) and the Quality of Life in Epilepsy Inventory-31 (QOLIE-31). The data were analysed using SPSS for Windows (version 17.0). Univariate correlation and multiple stepwise regression analyses were performed to explore the association between possible prognostic variables (independent variables) and QOLIE-31 overall and subscale scores (dependent variables). RESULTS: Analysis showed that demographic factors: employment and education; seizurerelated factors: seizure severity, seizure frequency, antiepileptic drug therapy and comorbid depressive disorder were the variables signifi cantly associated with QOLIE-31 overall score (p < 0.01). A three variable model accounted for 64.8% of the variance in QOLIE-31 overall score including seizure severity, comorbid depression and seizure frequency. CONCLUSIONS: Clinical factors are the strongest predictors of QOL of women with epilepsy in our study, seizure severity and comorbid depression being the main contributors. Paying attention to the psychological needs of women with epilepsy will have a positive effect on their QOL.
INTRODUCTION
Depressive disorders are the most frequent psychiatric comorbidity in epilepsy. Since women are twice as likely than men to suffer from depression, female gender could be considered a major risk factor for developing this condition. Converging lines of evidence suggest that sex hormones, which are known to contribute to remodeling the hippocampus, play a pivotal role in both epilepsy and depression. 1, 2 Depressive mood affects negatively quality of life (QOL) ratings, sometimes having greater impact than seizure-related variables. Women with epilepsy of fertile age (estimated to be 25% of patients with epilepsy) are a specifi c subgroup at risk of comorbid depression in consequence of certain biopsychosocial demands. 3 
AIM
The aim of the present study was to assess simultaneously the role played by multiple domains: psychological (mood), epilepsy specifi c, and demographic, in determining the perception of QOL in women with epilepsy of fertile age.
SUBJECTS AND METHODS
A psychiatric assessment was carried out of all 65 women with epilepsy. Patients with comorbid chronic somatic or neurological diseases were ex- cluded from the sample. Women with psychiatric comorbidity other than depression were not included in the analysis. Comorbid depressive disorder was diagnosed according to ICD-10 criteria. The Hamilton Depression Rating Scale (HAMD-17) was used to evaluate the severity of the depressive disorder. 4 The HAMD-17 is a 17-item questionnaire exploring 10 domains associated with depression: mood, anxiety, sexual function, appetite, sleep, functional status, physical symptoms, hypochondriasis, diurnal variation, general psychiatric distress. To quantify symptom severity, for each item, a score is devised ranging from 0 (normal) to 2 or 4 (maximal impairment). Based on HAM-D-17 scores, depression was defi ned as mild (7-17 points), moderate (18-24 points) and severe ( < 24 points).
The Seizure Severity Questionnaire (SSQ) was included as a self-report assessment which categorizes seizures into three phases: warning, ictal activity and postictal recovery. The recovery phase is subdivided into three components as cognitive, emotional and physical aspects of recovery, each rated for frequency, severity and bothersomeness. 5 The Quality of Life in Epilepsy Inventory-31 (QOLIE-31), a self-administered questionnaire, was used for assessment of QOL. It includes seven subscales: overall quality of life, seizure worry, emotional well-being, energy/fatigue, cognitive function, medication effects and social function. The responses can yield seven individual scores (per subtests) and an overall (composite) score. Higher scores indicate better QOL. 6 The questionnaires were translated into Bulgarian following international rules (translation, backtranslation and cognitive debriefi ng) and evaluated for validity and reliability.
A questionnaire for demographic (gender, age, education, marital status, cohabitation, employment) and seizure-related variables (seizure type and frequency, age at seizure onset, duration of epilepsy, antiepileptic drug therapy) was completed. Data analysis were carried out using SPSS for Windows (version 17.0). Univariate correlation analysis using Pearson's correlation coeffi cient for the quantitative and Spearman's rank correlation coeffi cient for the qualitative variables outlined the factors that infl uenced the most the variance of the QOLIE-31 overall and subscales scores. Determinants that were signifi cantly associated with the QOLIE-31 overall and subscales scores in the univariate analysis (p < 0.05) were included in a stepwise multivariate analysis as independent variables. As dependent variables, QOLIE-31 overall and the seven subscores were processed separately, thus eight separate multiple regression analyses for each domain were performed. The beta value was used as a measure of how strongly each predictor variable infl uences the criterion variable. The adjusted R² was used to assess the rate of variance of the domain score explained by the full model. Sets of best predictors of composite QOLIE-31 score and subscale scores were determined.
RESULTS
Comorbid depressive disorder affected 20 (30.77%) of all evaluated women with epilepsy. Based on the HAMD-17 scores it was defi ned as mild in 16 (24.6%), moderate in 3 (4.6%) and severe in 1 (1.5%) of the depressed women. Following the univariate analysis employment and education, out of the demographic factors, seizure severity, seizure frequency and antiepileptic drug therapy (AED), out of the seizure-related factors and comorbid depressive disorder were the variables signifi cantly associated with QOLIE-31 overall score (Tables 1,  2 ). The relation of the demographic and seizurerelated variables to QOLIE-31 overall score was inverse for seizure severity, seizure frequency and AED, i.e., greater seizure severity, higher seizure frequency and polypharmacy correlated to lower overall QOL scores and direct for education and employment, i.e., higher education and employment correlated to higher QOL overall score. Comorbid depression had an inverse relation to the scores, i.e., higher levels of depression correlated with lower QOL scores. Regarding subscales two more variables showed signifi cant inverse correlation to the scores: age -of Seizure Worry and Overall Quality of Life and duration of epilepsy -of Social Function. None of the evaluated variables was signifi cantly associated to Medication Effects. Table 3 shows the results of multiple regressions examining the contribution of independent variables to QOLIE-31 overall score and subscale scores. A three variable model accounted for 64.8% of the variance in QOLIE-31 overall score including seizure severity (47.2%), comorbid depression (12.8%) and seizure frequency (5.8%). Predicting variables respectively for the Seizure Worry subscale were: seizure severity and employment (66.4% of the variance), Cognitive Function -seizure severity, seizure frequency and comorbid depression (25.7% of the variance) and Social Function -seizure severity, seizure frequency and comorbid depression (53% of the variance). Three of the subscales of QOLIE-31, Overall Quality of Life, Emotional Well-Being and Energy/ Fatigue, had the same set of predictors -comorbid depression and seizure severity, accounting respectively for 40.3%, 46.4% and 39.5% of the variance in the scores.
DISCUSSION
Our results suggests that women with epilepsy of childbearing age are at high risk of depression (overall 30.77%). 1, 7 Different rates reported by authors (27% -55%) are largely dependent on the population samples and the use of different diagnostic tools. 8 Even with these limitations the strong association between epilepsy and depression in women cannot be denied. Recent advances in the understanding of the action of sex steroids on brain and the pathophysiology of depression have provided a hypothetical framework that may functionally connect epilepsy, ovarian hormone levels and depression. The hippocampus plays a critical role in both seizure activity and mood disorders, which suggests that pathology in this brain area might provide a link between epilepsy and depression. 9 The results of our study confi rm that QOL in women with epilepsy, measured by QOLIE-31 scores, strongly refl ects affective state, primarily depressed mood as measured by the HAMD-17. Psychiatric comorbidity remained a signifi cant predictor for QOLIE-31 overall score as well as all subdomains except Seizure Worry and Medication Effects. Our results replicate that higher levels of depression, measured by HAMD -17 scores, correlate strongly with lower QOL scores and vice versa. 7, 10, 11 Therefore, recognition and management of comorbid depression should be part of the routine standard of care in epilepsy clinics.
The role of the demographic factors in our sample is weak -none of them proved to be a predicting variable for QOLIE-31 scores. Education and employment were signifi cant predictors in the univariate analysis but vanished in the multiple regression. Similar results were reported by other studies, with no gender specifi c differences. 10, 12, 13 Seizure frequency, traditionally considered as the best predictor of QOL in epilepsy plays a modest role in our study, being a contributor to QOLIE-31 overall score, Cognitive function and Social function subscores. Our results show a strong relationship between seizure severity and QOL in women with epilepsy, a relation however incompletely explored and limited by the scope of the seizure severity scale used. On the other hand depression has been proved to have a strong infl uence on patients' reporting of seizure severity although the direction of a possible causal relationship is being discussed. 14 
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CONCLUSIONS
Our results indicate that clinical factors are the strongest predictors of QOL of women with epilepsy, seizure severity and comorbid depression being the main contributors. Drawing attention to the psychological needs of women with epilepsy will have a positive effect on their QOL. 7 
